Zobrazeno 1 - 10
of 308
pro vyhledávání: '"H. Cheema"'
Autor:
Gerges Abdelsayed, Danish Ali, Andrew Malone, Jemil Saidi, Manoj Myneni, Keshava Rajagopal, Faisal H. Cheema, Aamir Hameed
Publikováno v:
Applications in Engineering Science, Vol 12, Iss , Pp 100115- (2022)
Cardiovascular diseases are the leading cause of morbidity and mortality and a huge economic burden on the healthcare system globally. Both pharmacological and device based treatment options have emerged over the years, however, it is still a ‘holy
Externí odkaz:
https://doaj.org/article/5a798a49cdbe4624a01f4c56f971fcbc
Autor:
Gowtham R. Grandhi, Javier Valero-Elizondo, Reed Mszar, Eric J. Brandt, Amarnath Annapureddy, Rohan Khera, Anshul Saxena, Salim S. Virani, Ron Blankstein, Nihar R. Desai, Michael J. Blaha, Faisal H. Cheema, Farhaan S. Vahidy, Khurram Nasir
Publikováno v:
American Journal of Preventive Cardiology, Vol 2, Iss , Pp 100034- (2020)
Background: While optimal cardiovascular risk factor (CRF) profile is associated with lower mortality, morbidity, and healthcare expenditures among individuals with atherosclerotic cardiovascular disease (ASCVD), less is known regarding its impact on
Externí odkaz:
https://doaj.org/article/9209291b7d394236a37a035c7e2fec4d
Autor:
Rajesh Venkataraman, Pranav Loyalka, Carlos Encarnacion, Hazim J. Safi, Faisal H. Cheema, Keshava Rajagopal
Publikováno v:
The Annals of Thoracic Surgery. 115:e33-e35
Autor:
Celeste A. Hall, Jeffrey P. Jacobs, Alfred H. Stammers, James D. St. Louis, J.W. Awori Hayanga, Michael S. Firstenberg, Linda B. Mongero, Eric A. Tesdahl, Keshava Rajagopal, Faisal H. Cheema, Kirti Patel, Tom Coley, Anthony K. Sestokas, Marvin J. Slepian, Vinay Badhwar
Publikováno v:
The Annals of Thoracic Surgery. 114:61-68
We reviewed our experience with 505 patients with confirmed coronavirus disease-2019 (COVID-19) supported with extracorporeal membrane oxygenation (ECMO) at 45 hospitals and estimated risk factors for mortality.A multi-institutional database was crea
Publikováno v:
ASAIO Journal.
Autor:
Ahmad Liaquat, Absar Akram, Muhammad Abbas, Bilal Hussain, Ehsan Ul Haq, S. S. Masood Tirmazi, Ali H. Cheema, Abeera Ali Mir
Publikováno v:
Pakistan Journal of Medical and Health Sciences. 16:22-24
The purpose of this article is to gauge the level of understanding regarding oral precancerous lesions and conditions of fresh graduates and underscore the underlying deficiencies present to amplify the early detection rate in a bid to decrease morta
Autor:
James D. St. Louis, Vinay Badhwar, Jeffrey P. Jacobs, Marvin J. Slepian, Eric A. Tesdahl, Keshava Rajagopal, Kirti Patel, Tom Coley, Faisal H. Cheema, Anthony K. Sestokas, J.W. Awori Hayanga, Michael S. Firstenberg, Alfred H. Stammers, Linda B. Mongero
Publikováno v:
The Annals of Thoracic Surgery. 113:1452-1460
BACKGROUND: The role of ECMO in the management of patients with COVID-19 continues to evolve. The purpose of this manuscript is to review a multi-institutional clinical experience in 200 consecutive patients at 29 hospitals with confirmed COVID-19 su
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 165:2112-2113
Autor:
Carl P. Walther, Jingbo Niu, Wolfgang C. Winkelmayer, Faisal H. Cheema, Ajith P. Nair, Jeffrey A. Morgan, Savitri E. Fedson, Anita Deswal, Sankar D. Navaneethan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 14 (2018)
Background People with end‐stage renal disease (ESRD) are at risk for advanced heart failure, but little is known about use and outcomes of durable mechanical circulatory support in this setting. We examined use and outcomes of implantable ventricu
Externí odkaz:
https://doaj.org/article/26123c75e0f24b9db94d5a9393d06ad2
Autor:
Yiling Fan, Aamir Hameed, Faisal H. Cheema, Garry P. Duffy, Ellen T. Roche, Grainne Malone, Saeed Shoar, Luca Rosalia, Claire Conway, Robert A. Byrne, Caglar Ozturk, Andrew Malone
Publikováno v:
JACC: Basic to Translational Science
Highlights • The prevalence of heart failure with preserved ejection fraction among patients who present with symptoms of heart failure is approximately 50%. • Pharmacologic therapy has not conclusively shown benefits in morbidity and mortality i